News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
541,187 Results
Type
Article (45831)
Company Profile (120)
Press Release (495225)
Multimedia
Podcasts (114)
Webinars (19)
Section
Business (145696)
Career Advice (2411)
Deals (28134)
Drug Delivery (124)
Drug Development (68393)
Employer Resources (154)
FDA (15821)
Job Trends (12027)
News (265249)
Policy (29847)
Tag
Academia (2308)
Academic (1)
Accelerated approval (17)
Adcomms (35)
Allergies (106)
Alliances (36225)
ALS (123)
Alzheimer's disease (1568)
Antibody-drug conjugate (ADC) (180)
Approvals (15795)
Artificial intelligence (352)
Autoimmune disease (45)
Automation (19)
Bankruptcy (312)
Best Places to Work (9196)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (69)
Bladder cancer (111)
Brain cancer (41)
Breast cancer (379)
Cancer (3111)
Cardiovascular disease (286)
Career advice (2026)
Career pathing (35)
CAR-T (189)
CDC (49)
Cell therapy (526)
Cervical cancer (26)
Clinical research (56905)
Collaboration (1026)
Company closure (4)
Compensation (835)
Complete response letters (50)
COVID-19 (2671)
CRISPR (68)
C-suite (433)
Cystic fibrosis (116)
Data (3427)
Decentralized trials (2)
Denatured (24)
Depression (94)
Diabetes (378)
Diagnostics (5375)
Digital health (21)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (143)
Drug pricing (164)
Drug shortages (33)
Duchenne muscular dystrophy (178)
Earnings (60823)
Editorial (53)
Employer branding (20)
Employer resources (138)
Events (79613)
Executive appointments (812)
FDA (17934)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (904)
Gene editing (143)
Generative AI (28)
Gene therapy (438)
GLP-1 (928)
Government (4093)
Grass and pollen (7)
Guidances (323)
Healthcare (14882)
HIV (42)
Huntington's disease (33)
IgA nephropathy (50)
Immunology and inflammation (215)
Immuno-oncology (18)
Indications (39)
Infectious disease (2866)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (74)
Intellectual property (151)
Interviews (452)
IPO (14160)
IRA (56)
Job creations (3170)
Job search strategy (1668)
Kidney cancer (14)
Labor market (60)
Layoffs (585)
Leadership (30)
Legal (6999)
Liver cancer (81)
Longevity (10)
Lung cancer (450)
Lymphoma (227)
Machine learning (21)
Management (51)
Manufacturing (484)
MASH (113)
Medical device (11407)
Medtech (11419)
Mergers & acquisitions (14726)
Metabolic disorders (995)
Multiple sclerosis (102)
NASH (22)
Neurodegenerative disease (161)
Neuropsychiatric disorders (48)
Neuroscience (2367)
NextGen: Class of 2025 (4993)
Non-profit (3183)
Now hiring (23)
Obesity (513)
Opinion (248)
Ovarian cancer (99)
Pain (136)
Pancreatic cancer (134)
Parkinson's disease (197)
Partnered (19)
Patents (353)
Patient recruitment (243)
Peanut (50)
People (43505)
Pharmaceutical (32)
Pharmacy benefit managers (25)
Phase I (17019)
Phase II (24648)
Phase III (20194)
Pipeline (2321)
Policy (276)
Postmarket research (2209)
Preclinical (6924)
Press Release (28)
Prostate cancer (163)
Psychedelics (46)
Radiopharmaceuticals (222)
Rare diseases (556)
Real estate (4280)
Recruiting (61)
Regulatory (21843)
Reports (37)
Research institute (2073)
Resumes & cover letters (402)
Rett syndrome (11)
RNA editing (11)
RSV (58)
Schizophrenia (115)
Series A (158)
Series B (120)
Service/supplier (9)
Sickle cell disease (69)
Special edition (23)
Spinal muscular atrophy (130)
Sponsored (39)
Startups (2772)
State (1)
Stomach cancer (17)
Supply chain (88)
Tariffs (83)
The Weekly (89)
Vaccines (956)
Venture capital (62)
Weight loss (364)
Women's health (42)
Worklife (21)
Date
Today (126)
Last 7 days (426)
Last 30 days (2092)
Last 365 days (28828)
2025 (20349)
2024 (31419)
2023 (35008)
2022 (45107)
2021 (48560)
2020 (45575)
2019 (36291)
2018 (27446)
2017 (27872)
2016 (25851)
2015 (28023)
2014 (21828)
2013 (17849)
2012 (19027)
2011 (19416)
2010 (17561)
Location
Africa (679)
Alabama (56)
Alaska (6)
Arizona (190)
Arkansas (10)
Asia (31696)
Australia (5543)
California (7832)
Canada (2030)
China (635)
Colorado (314)
Connecticut (356)
Delaware (204)
Europe (77975)
Florida (1194)
Georgia (253)
Hawaii (3)
Idaho (38)
Illinois (570)
India (35)
Indiana (322)
Iowa (18)
Japan (237)
Kansas (95)
Kentucky (20)
Louisiana (12)
Maine (66)
Maryland (1065)
Massachusetts (5790)
Michigan (220)
Minnesota (435)
Mississippi (3)
Missouri (88)
Montana (12)
Nebraska (19)
Nevada (90)
New Hampshire (56)
New Jersey (2167)
New Mexico (14)
New York (2094)
North Carolina (1101)
North Dakota (7)
Northern California (3600)
Ohio (210)
Oklahoma (11)
Oregon (28)
Pennsylvania (1596)
Puerto Rico (11)
Rhode Island (27)
South America (1038)
South Carolina (42)
South Dakota (1)
Southern California (3027)
Tennessee (121)
Texas (1158)
United States (28154)
Utah (202)
Virginia (194)
Washington D.C. (68)
Washington State (638)
West Virginia (4)
Wisconsin (74)
541,187 Results for "bavarian nordic a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bavarian Nordic Announces First Half 2025 Results
August 22, 2025
·
7 min read
Press Releases
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
August 1, 2025
·
2 min read
Press Releases
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
July 10, 2025
·
3 min read
Press Releases
Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine
July 22, 2025
·
5 min read
Press Releases
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
June 12, 2025
·
5 min read
Press Releases
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
June 18, 2025
·
2 min read
Press Releases
Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women
June 26, 2025
·
3 min read
Press Releases
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
April 17, 2025
·
6 min read
Press Releases
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
April 10, 2025
·
2 min read
Press Releases
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
April 10, 2025
·
2 min read
1 of 54,119
Next
